The Buzz Surrounding HempFusion Wellness Inc. (OTCQX: CBDHF) (TSX: CBD.U) | Financial Buzz

The Buzz Surrounding HempFusion Wellness Inc. (OTCQX: CBDHF) (TSX: CBD.U)

About:

HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations.

   U.S. HEMP AUTHORITY CERTIFIED

Our Behind the Buzz Show Featuring
HempFusion Wellness Inc.:

Investor Recap

CBD Products

CBD Capsules

HempFusion CBD Capsules are a simple way to nourish your endocannabinoid system with the exact serving calibrated and contained in easy-to-swallow cbd capsules.

  • Enhanced with DNA-Verified Broad-Spectrum Hemp Extract CBD
  • Convenient – easy-to-swallow, customize your serving
  • Whole Food Hemp Complex – more terpenes and omegas to support the entourage effect
  • Board Certified Naturopathic Doctor Formulated

CBD Tincture

Each person’s system reacts differently to CBD. HempFusion’s CBD liquid tinctures let you tailor your serving and nourish your endocannabinoid system with the amount of CBD that works best for your body. CBD tinctures enable you to harmonize body and mind in a convenient liquid.

  • Enhanced with DNA-Verified Broad-Spectrum Hemp Extract CBD
  • Whole Food Hemp Complex – more terpenes and omegas to support entourage effect
  • Formula-specific Benefits – stress, sleep and energy formulas feature proven botanicals
  • Board Certified Naturopathic Doctor Formulated

Over-the-Counter Topicals

Over-The-Counter (OTC) drug-listed topical line to provide relief for pain and help reduce the symptoms of eczema and acne. This line includes broad-spectrum hemp extract CBD that harnesses true broad-spectrum power plus a greater diversity of naturally-occurring cannabinoids and other compounds. They work together to support the entourage effect and deliver the most benefits.

The Process

Farming Practices

  • HempFusion exclusively grows in Europe
  • USDA Certified Organic to avoid the use of pesticides, herbicides and GMOs. We are excited to announce five new products that are USDA Certified Organic, set to launch soon
  • DNA validated as European Agricultural hemp
  • Pre-validation of the soil prior to planting

Oil Extraction Method

  • hemp extract is created using a proprietary method of solvent-free C02 extraction that we call the HOPE process (HempOnePassExtraction™).
  • All other botanicals used in our formulations are properly tested to make sure they are free of residual solvents and other potential contaminants

Manufacturing Practices

  • Manufactured only in FDA-registered facilities
  • All of the hemp is certified and DNA validated as European Agricultural Hemp
  • All manufacturing facilities are independently certified as cGMP compliant (current good manufacturing practices)

Recent Developments

April 15, 2021 - HempFusion Comments on Recent Trading Activity, All Projects, Incl. Five Channel Strategy, in Motion and Strong Cash-On-Hand

HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”) issues this press release in response to recent trading activity and the decline in its share price. The Company wishes to reassure investors that all aspects of its business, including the five-channel distribution strategy, are in-motion and that there are no undisclosed events that the Company believes warrant the share price decline.

The Company has disclosed all material information in its press releases and other disclosure documents in compliance with its continuous disclosure obligations. HempFusion further confirms that its material contracts and relationships with its key distributors, both domestic and international, are in good standing.

“HempFusion is powering ahead, and I wanted to take the time to reassure investors that the decline in the stock price cannot be explained by an undisclosed development at the Company, as all material information has been disclosed and is readily available,” commented Jason Mitchell, N.D., the Company’s Co-Founder and Chief Executive Officer. “We believe the Company is in the strongest position it has ever been with significant partnerships, developments, new distributors, and international channels deep in development, including a significant sales pipeline, consumers returning to stores, multiple international expansion initiatives, and a robust balance sheet, including a strong cash position of approximately US$9.3 million as of December 31, 2020 in addition to the closing of the Company’s US$17 million initial public offering on January 6, 2021.

HempFusion remains, according to Brightfield Group, the #2 ranked CBD brand in Awareness. Probulin Probiotics finished 2020 as the fastest-growing Probiotic brand out of the Top 15 in the US, according to SPINS. The Company’s OTC Tropical products have ranked #1 in both sales dollars and units sold at a major Food & Drug Mass retailer in the US, according to NielsenIQ, and the Company has relaunched its website and digital strategy, resulting in a 10x increase to traffic. The Company remains excited and committed to strengthening its existing position as a leading health and wellness CBD company with a global reach.

For Full Release:  https://www.businesswire.com/news/home/20210415006013/en/HempFusion-Comments-on-Recent-Trading-Activity-All-Projects-Incl.-Five-Channel-Strategy-in-Motion-and-Strong-Cash-On-Hand

April 06, 2021 - HempFusion's Products Enter Asia Through Alibaba Group’s Tmall Global

HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce following its launch of Probulin Probiotics on Alibaba Group Holding’s Tmall Global (“Tmall”), it has now received conditional approval to launch HempFusion’s CBD products on Tmall, the world’s largest cross border online marketplace reaching more than 750 million potential new consumers across mainland China, Hong Kong, Macau and Taiwan.

“We are incredibly excited to receive approval for HempFusion’s flagship store from Tmall, joining our subsidiary, Probulin Probiotics, on China’s leading eCommerce platform reaching the world’s largest consumer base,” said Jon Visser, HempFusion’s Chief Revenue Officer. “To be one of the first publicly traded CBD companies on the platform provides us with significant competitive advantages that have the potential to add considerable revenue to our Company,’’ continued Mr. Visser.

HempFusion’s topicals with CBD are expected to launch on Tmall soon and will include its OTC drug listed Acne Relief, Eczema Relief, and Sports Relief Creams, Pain Relief and Sports Pain Relief Balms, Pain Relief Gel and Wound Ointment, with more products expected to follow. These unique formulations include a proprietary skin nourishing and moisturizing base with Aloe Vera, Shea butter, Jojoba oil, Hemp derived omega fatty acids and CBD, as well as many other botanicals.

“Building on our established relationship with the Alibaba Group and Tmall, and introducing our premium HempFusion OTC Drug Listed Topical products throughout this premier Asian eCommerce platform, has been a major focus of our strategic expansion plan,” stated Jason Mitchell, N.D., HempFusion’s Co-Founder and CEO. “We are now accessing one of the largest online consumer groups in the world with products formulated with approved drug monograph ingredients such as menthol for ailments such as pain. These products have already performed as best in class in select retailers in the United States, and we’re excited to see that follow through in the world’s largest market,” continued Dr. Mitchell.

Tmall, the third most visited website in the world, provides unique opportunities to raise brand awareness and drive conversions through comprehensive digital marketing campaigns, including shoppable live streams with product demonstrations and special offers. Brand hosts drive traffic through live, digital interaction, resulting in more engaged consumers staying tuned in longer.

“Our highest profile influencers are looking forward to engaging with the enormous Asian market through this live stream eCommerce format,” stated Mr. Visser. “They’ll deliver authentic, first-person testimonials and experiences, interacting and educating new consumers on the many wellness benefits of HempFusion products,” continued Mr. Visser.

HempFusion is ranked #2 in brand awareness according to a recent survey conducted by Brightfield Group. “Our goal is to achieve the same brand awareness and reach that top spot in Greater China,” added Dr. Mitchell.

For Full Release: https://www.businesswire.com/news/home/20210406005360/en/HempFusions-Products-Enter-Asia-Through-Alibaba-Group%E2%80%99s-Tmall-Global

February 03, 2021 - HempFusion Announces US Symbol, CBDHF

DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTC Pink:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce it has secured its OTC Markets trading symbol, “CBDHF,” allowing a broader U.S. investor audience the ability to trade shares in the Company.

“As a US-based CBD company, this important step allows a broader range of US investors to access the Company,” commented Jason Mitchell N.D., HempFusion’s co-founder and CEO. “Additionally, we have applied for an OTCQX listing and DTC eligibility, which we expect in the coming weeks subject to the approval of the OTCQX and the satisfaction of certain listing requirements.”

For Full Release: https://www.businesswire.com/news/home/20210203005272/en/HempFusion-Announces-US-Symbol-CBDHF

February 02, 2021 - HempFusion Wellness Inc. Becomes Exclusive CBD and Probiotics Sponsor of Loenbro Motorsports for 2021 Racing Season

HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the Company”), is pleased to announce an exclusive partnership with Loenbro Motorsports, one of the world’s leading race teams, making HempFusion CBD, a leading brand utilizing the power of whole-food hemp nutrition, and Probulin, one of the fastest growing probiotic brands in the U.S. according to SPINs reported data, the exclusive sponsors in their respective categories for the 2021 racing season.

The sponsorship kicks off this evening with the debut of the HempFusion #00eh car at the 50th Annual DIRTcar Nationals at Volusia Speedway near Daytona. Loenbro Motorsports’ legendary driver, Steve Arpin, will be behind the wheel, looking for another trip to Victory Lane.

“Thanks to Loenbro Motorsports’ founders, Paul and Jon Leach, for this exciting partnership providing HempFusion and Probulin many incredible opportunities to engage and educate millions of dedicated race fans across the country in the health and wellness benefits of both CBD and probiotics,” commented Ian deQueiroz, HempFusion’s Chief of Brand Strategy. “We couldn’t ask for a better partner than Steve. He’s a true, humble champion who’s always prioritized the fans, making him one of the most popular drivers in the racing community.”

As the exclusive category sponsors, HempFusion and Probulin’s marketing assets include the primary title position on Steve Arpin’s racecars, fire suit and helmet, a full wrap of the race team hauler, exclusive sweepstakes and VIP hospitality at events throughout the year, and additional branding and social media opportunities.

“I’m very excited to be partnering with both HempFusion and Probulin,” commented Steve Arpin. “I’ve tried CBD products in the past but being able to finally find USDA Certified Organic tinctures allows me to stay even more aligned with my overall wellness goals. Their OTC topicals are best in class and both myself and my wife have fallen in love with Probulin as well. Dealing with gluten intolerance, my wife has always struggled with digestive issues. Probiotics have long been something she uses to support her digestive system and finding an option to help her live more comfortably without gluten has been a constant challenge. Thank you HempFusion and Probulin for creating such amazing products!”

HempFusion’s Whole Food Hemp Complex™ powered tinctures, capsules and topicals, include support in areas such as sleep, stress, energy and overall well-being. One of only a few brands to have earned USDA Organic Certification for its CBD tinctures, HempFusion uses only DNA-verified, organically grown, heirloom strains of hemp.

All of Probulin’s products represent the next generation of probiotics for supporting digestive health and immune function. Always shipped cold and protected, Probulin probiotics utilize the scientifically validated MAKTrekⓇ 3-D Probiotic Delivery System, designed to protect and nourish the probiotics so that more can arrive alive in the gut.

HempFusion’s family of brands are available through approximately 4,000 retail locations across all 50 states and select international locations and from HempFusion.com and Probulin.com.

For Full Release: https://www.businesswire.com/news/home/20210202005449/en/HempFusion-Wellness-Inc.-Becomes-Exclusive-CBD-and-Probiotics-Sponsor-of-Loenbro-Motorsports-for-2021-Racing-Season

January 28, 2021 - HempFusion Wellness Inc. Launches Probulin Total Care Immune Probiotic for National Distribution

HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its wholly-owned subsidiary, Probulin Probiotics, LLC (“Probulin”), has launched its Total Care Immune probiotic product nationally with a number of major retailers including Sprouts Farmers Markets, Abby’s and Fresh Thyme Markets. Probulin’s Total Care Immune is expected to arrive on shelves nationwide in early February 2021, with online sales available now at Probulin.com.

“Consumers are turning increasingly more to probiotics to support their body’s digestive health and immune function,” commented Jason Mitchell, N.D., HempFusion’s Chief Executive Officer. “By combining two top dietary supplement ingredients, probiotics and elderberry, Probulin is creating the next generation of innovative probiotic products and, as evidenced by our immediate national rollout, retailers continue to display strong demand for these products,” continued Dr. Mitchell.

Probulin’s Total Care Immune probiotic combines the daily digestive and immune support of pre-, pro- and post-biotics with the immune-supporting power of elderberry. The product includes the following unique features:

  1. 100 mg of Eldermune™ (equivalent to 4,225 mg of whole elderberry);
  2. Scientifically formulated with 10 probiotic strains such as lactobacillus acidophilus, lactobacillus reuteri, lactobacillus rhamnosus and bifidobacteria lactis;
  3. 20 Billion cfu†, including 8 Billion cfu† from fermented fruits and vegetables;
  4. Probiotic + Prebiotics +Postbiotics for TOTAL microbiome support**; and
  5. Proprietary MAKTrek® 3-D Probiotic Delivery System to ensure better survival.

“A major differentiator for HempFusion is the way our probiotic products are shipped. We always ship our probiotic products cold and protected while the scientifically validated MAKTrekⓇ 3-D Probiotic Delivery System is designed to protect and nourish the probiotics so that more can arrive alive in the gut. This results in a positive influence on the microbiome which is vital to overall gut health,” continued Dr. Mitchell.

Probulin is recognized as one of the fastest-growing probiotics brands in the American Natural Products Industry, according to SPINs syndicated data. All of Probulin’s products represent the next generation of probiotics for digestive health and immune support based entirely on cultured food and scientifically studied strains. Probulin products include the latest advancements in fermented fruits and vegetables, a prebiotic and the MAKTrek® 3-D Probiotic Delivery System, which helps ensure better survival of the probiotics. 70% of the human immune system resides in the stomach, making digestive and immune health intricately linked.

For Full Release: https://www.businesswire.com/news/home/20210128005401/en/HempFusion-Wellness-Inc.-Launches-Probulin-Total-Care-Immune-Probiotic-for-National-Distribution

January 26, 2021 - HempFusion Announces Inclusion in Leading Cannabis ETFs

HempFusion Wellness Inc. (TSX:CBD.U) (FWB:8OO) (“HempFusion” or the “Company”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ETFs”), AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) and AdvisorShares Pure Cannabis ETF (NYSE:YOLO).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“AUM”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

“We are pleased the AdvisorShares ETFs have initiated positions in our Company. This represents a strong milestone for the Company and provides us added exposure to the investment community,” commented Jason Mitchell, N.D., HempFusion’s co-founder and CEO. “Inclusion in these ETFs brings additional exposure to potential new investors as well as generates value for existing shareholders. With our listing on the TSX, current market capitalization, and liquidity, we believe we now meet many cannabis-related ETFs’ inclusion requirements, and we look forward to other potential ETFs’ initiating positions.”

For Full Release: https://www.businesswire.com/news/home/20210126005426/en/HempFusion-Announces-Inclusion-in-Leading-Cannabis-ETFs

January 06, 2021 - HempFusion Wellness Inc. Completes USD$17,000,000 Initial Public Offering and Commences Trading on the Toronto Stock Exchange

HempFusion Wellness Inc. (“HempFusion” or the “Company”) is pleased to announce that it has completed its initial public offering of 7,000,000 common shares of the Company (the “Offered Shares”) at a price of USD$1.00 per Offered Share (the “Offering Price”) for gross proceeds of USD$7,000,000 (the “Share Offering”) and 10,000,000 units of the Company (the “Units”) at the Offering Price per Unit for gross proceeds of USD$10,000,000 (the “Unit Offering” and collectively with Share Offering, the “Offering”).

HempFusion’s common shares (the “Common Shares”), the common share purchase warrants comprising the Units (the “Warrants”) and the common share purchase warrants issued in connection with the Company’s offering of units completed in August 2019 (the “2019 Warrants”) will commence trading on the Toronto Stock Exchange (the “TSX”) today under the following symbols:

  • CBD.U – the Common Shares (including the Offered Shares, the Unit Shares (as described below) and the Warrant Shares (as described below));
  • CBD.WT.V – the Warrants; and
  • CBD.WT.U – the 2019 Warrants.

“We are incredibly excited to have completed our initial public offering and begin trading on the Toronto Stock Exchange,” commented Jason Mitchell, N.D., HempFusion’s CEO. “The additional USD$17 million in capital adds to our healthy treasury, providing us with a solid foundation to build from and execute on our strategic plans for 2021 and beyond. Our goals include increased investment into research and development, expanding our sales and distribution networks, and firmly establishing HempFusion as a leader in the dynamic global CBD industry.”

The Offering

The Offering was completed through a syndicate of agents led by Canaccord Genuity Corp., as sole bookrunner, and including Haywood Securities Inc. and PI Financial Corp. (collectively, the “Agents“). Each Unit offered under the Unit Offering is comprised of one Common Share (each a “Unit Share”) and one-half of ‎one Warrant. ‎Each Warrant entitles the holder to purchase one Common Share (each, a ‎‎“Warrant Share”) at a price of USD$1.20 per Warrant Share at ‎any time until January 6, 2026. The Unit ‎Shares are subject to a contractual hold period and may not be ‎sold, transferred, pledged, hypothecated or otherwise assigned or traded until May 6, 2021. The ‎Warrant Shares will be subject to a ‎contractual hold period and may not be sold, transferred, pledged, hypothecated or otherwise assigned or traded until July 6, 2022. ‎

The exercise price of the 2019 Warrants, each of which is exercisable to acquire one Common Share (each a “2019 Warrant Share”, and together with the Offered Shares, the Units, the Unit Shares, the Warrants, the Warrant Shares and the 2019 Warrants, the “Securities”), was subject to adjustment based on the Offering Price and has now been confirmed at USD$0.85 per 2019 Warrant Share. The 2019 ‎Warrant Shares will be subject to a ‎contractual hold period and may not be sold, transferred, pledged, hypothecated or otherwise assigned or traded until July 6, 2022. ‎

Under the terms of an agency agreement entered into between the Company and the Agents, the Company has granted the Agents an over-allotment option (the “Over-Allotment Option“), exercisable in whole or in part, at the sole discretion of the Agents, at any time and from time to time, for a period of 30 days following the closing of the Offering, to purchase up to an additional 1,050,000 Offered Shares at the Offering Price per Offered Share and 1,500,000 Units at the Offering Price per Unit, for additional gross proceeds to the Company of up to USD$2,550,000.

No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities of HempFusion in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws. Accordingly, the Securities may not be offered or sold within the United States, or to or for the account or benefit of any U.S. persons or any persons in the United States, absent exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. “United States” and “U.S. person” are as defined in Regulation S under the U.S. Securities Act.

January 05, 2021 - HempFusion Wellness Inc. Shares Posted for Trading on the Toronto Stock Exchange on January 6, 2021 Under the Symbol CBD.U

HempFusion Wellness Inc. (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares and certain other securities have been posted for trading on the Toronto Stock Exchange (the “TSX”) at the market opening on January 6, 2021, subject to customary closing procedures. Additional details in connection with the Company’s TSX listing will be provided in a subsequent news release expected to be disseminated the morning of January 6, 2021.

No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities of HempFusion in any jurisdiction in which such offer, solicitation or sale would be unlawful.

On Behalf of the Board of Directors,

HempFusion Wellness Inc.
Jason Mitchell, N.D.
Chief Executive Officer and Director

ABOUT HEMPFUSION

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs including, tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com.

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For hempfusion wellness inc., investor relations, video production, filming editing, news reporting, financial and corporate news dissemination, FinancialBuzz.com has been compensated ten thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.